Literature DB >> 24065659

MicroRNA-199a-3p is downregulated in gastric carcinomas and modulates cell proliferation.

W Peng1, Z-Y Chen, L Wang, Z Wang, J Li.   

Abstract

MicroRNAs (miRNAs) are small non-coding RNAs that regulate the translation of targeted mRNAs. An increasing amount of evidence indicates that miRNAs play important role in cancer pathogenesis, apoptosis, proliferation, and differentiation as oncogenes or tumor suppressors. Recently, miRNA-199a has been shown to be involved in many human cancers, although the role of miRNA-199a-3p in gastric cancer has not yet been evaluated. In the present study, the expression of miRNA-199a-3p was found to be significantly downregulated in human gastric cancer tissues and cells. miRNA-199a-3p induced anti-proliferation effects on human gastric cancer cells. Furthermore, using quantitative RT-PCR (real-time polymerase chain reaction) and luciferase reporter assays, mTOR was identified as a direct target gene of miRNA-199a-3p that is downregulated by it. In conclusion, our findings suggest that miRNA-199a-3p is associated with human gastric cancer through its ability to decrease cancer cell proliferation and target the mTOR signaling pathway, and, therefore, may provide a novel therapeutic target for the treatment of human gastric cancer.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24065659     DOI: 10.4238/2013.August.20.5

Source DB:  PubMed          Journal:  Genet Mol Res        ISSN: 1676-5680


  15 in total

1.  MiR-451 suppresses cell proliferation and metastasis in A549 lung cancer cells.

Authors:  Pin Yin; Rui Peng; Huimin Peng; Li Yao; Yan Sun; Li Wen; Tianhui Wu; Ji Zhou; Zheng Zhang
Journal:  Mol Biotechnol       Date:  2015-01       Impact factor: 2.695

Review 2.  MicroRNA and signaling pathways in gastric cancer.

Authors:  Z Zhang; Z Li; Y Li; A Zang
Journal:  Cancer Gene Ther       Date:  2014-07-25       Impact factor: 5.987

3.  MiR-199a inhibits the ability of proliferation and migration by regulating CD44-Ezrin signaling in cutaneous squamous cell carcinoma cells.

Authors:  Shao-Hua Wang; Jian-Da Zhou; Quan-Yong He; Zhao-Qi Yin; Ke Cao; Cheng-Qun Luo
Journal:  Int J Clin Exp Pathol       Date:  2014-09-15

Review 4.  Circulating microRNAs and long non-coding RNAs in gastric cancer diagnosis: An update and review.

Authors:  Ya-Kai Huang; Jian-Chun Yu
Journal:  World J Gastroenterol       Date:  2015-09-14       Impact factor: 5.742

Review 5.  MicroRNAs: promising chemoresistance biomarkers in gastric cancer with diagnostic and therapeutic potential.

Authors:  Christiane Matuszcak; Joerg Haier; Richard Hummel; Kirsten Lindner
Journal:  World J Gastroenterol       Date:  2014-10-14       Impact factor: 5.742

Review 6.  The functional sites of miRNAs and lncRNAs in gastric carcinogenesis.

Authors:  Xiangxiang Wan; Xiaoyun Ding; Shengcan Chen; Haojun Song; Haizhong Jiang; Ying Fang; Peifei Li; Junming Guo
Journal:  Tumour Biol       Date:  2015-02-01

7.  miR-199a and miR-497 Are Associated with Better Overall Survival due to Increased Chemosensitivity in Diffuse Large B-Cell Lymphoma Patients.

Authors:  Katharina Troppan; Kerstin Wenzl; Martin Pichler; Beata Pursche; Daniela Schwarzenbacher; Julia Feichtinger; Gerhard G Thallinger; Christine Beham-Schmid; Peter Neumeister; Alexander Deutsch
Journal:  Int J Mol Sci       Date:  2015-08-05       Impact factor: 5.923

Review 8.  May Circulating microRNAs be Gastric Cancer Diagnostic Biomarkers?

Authors:  Xiaoling Wu; Xiaohui Tan; Sidney W Fu
Journal:  J Cancer       Date:  2015-09-20       Impact factor: 4.207

9.  Microrna-199a-5p Functions as a Tumor Suppressor via Suppressing Connective Tissue Growth Factor (CTGF) in Follicular Thyroid Carcinoma.

Authors:  Dawei Sun; Shen Han; Chao Liu; Rui Zhou; Weihai Sun; Zhijun Zhang; Jianjun Qu
Journal:  Med Sci Monit       Date:  2016-04-11

10.  Serum microRNA-199a/b-3p as a predictive biomarker for treatment response in patients with hepatocellular carcinoma undergoing transarterial chemoembolization.

Authors:  Zelong Luo; Chao Feng; Peng Hu; Yong Chen; Xiao-Feng He; Yanhao Li; Jianbo Zhao
Journal:  Onco Targets Ther       Date:  2016-05-04       Impact factor: 4.147

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.